Immune regulation by SLAT, a Novel Th2-Expressed Protein
Immune regulation by SLAT, a Novel Th2-Expressed Protein
批准号:
7379906
负责人:
AMNON ALTMAN
金额:
$45.2万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2011-02-28
关键词:
AddressAntibodiesAntigensBackcrossingsBiochemicalBiochemical GeneticsBiologicalBlocking AntibodiesBone Marrow CellsCD4 Positive T LymphocytesCell physiologyCellsCellular biologyChromosome PairingComplexDevelopmentDiseaseDominant-Negative MutationEventFoundationsFractionationGenerationsGuanine Nucleotide Exchange FactorsHelper-Inducer T-LymphocyteImageImmuneKnockout MiceMapsMembraneMembrane MicrodomainsMessenger RNAMethodsMitogen-Activated Protein KinasesMolecularMusMutateOther FindingPersonal SatisfactionPhenotypePhosphotransferasesPhysiologicalPlayPredispositionProcessProteinsReceptor SignalingRecruitment ActivityRegulationRetroviridaeRoleSignal PathwaySignal TransductionSiteStimulusStructureSurfaceSynapsesT-Cell ReceptorT-LymphocyteTechniquesTh1/Th2 Differentiation PathwayTh2 CellsTransgenic OrganismsWorkZAP-70 GeneZAP-70 Kinasebasecellular imagingcytokineimmunological synapseinterestmembermutantnovelreceptorreceptor couplingreconstitutionresponsetranscription factor
中文摘要
我们最近分离出一种新的蛋白质,SLAT,一个新的Rac特异性激活剂亚家族的成员。
SLAT在Th 2细胞中上调,抗原刺激诱导其免疫突触定位和ZAP-
70结合,导致TCR募集和ZAP-70活化减少。我们两个人,非独家。
工作假设是:1)SLAT通过其与ZAP-70的结合抑制激酶的TCR募集和/或
活化,从而以促进Th 2分化的方式调节TCR信号传导的质量,
2)SLAT和/或其替代产物SLAT 2在Th 2细胞中起作用,
Cdc 42/Rac特定的全环基金;这项活动在确定不同的
在Th 2细胞中,IS和脂筏聚集的质量以及因此下游信号。我们将解决
这些假设,并分析其他方面的表达,功能和调控的SLAT通过探索
四个目的:1)使用原代小鼠T细胞,成像和生物化学技术,不同的刺激,和
受体阻断抗体,我们将分析SLAT/SLAT 2 mRNA或蛋白质的表达,研究它们的作用。
细胞内定位,绘制膜/IS定位所必需的残基,并评估
这一定位的意义。2)我们将对SLAT 1+小鼠进行详细分析,包括Th 1/Th 2
分化、近端和下游信号传导事件、抗体和T细胞应答以及易感性
与Th 1或Th 2表型优势相关的实验性疾病。3)我们将
通过绘制SLAT与ZAP-70(或Syk)之间的关联来探索SLAT与ZAP-70(或Syk)之间关联的生物学相关性
相互作用位点,并评估相互作用缺陷的SLAT或ZAP-70/Syk突变体,或显性的
ZAP-70/Syk阴性对Th 1/Th 1发育和活化的影响。4)我们将使用生物化学和遗传学
方法,包括SLAT 1+小鼠或用SLAT突变体重建的T细胞,以定位SLAT残基
负责全球环境基金的活动,研究管理SLAT全球环境基金活动的机制,并确定
这种活性对于SLAT的Th 2-偏斜效应和对于Th 2中IS的不同组织的意义
细胞这些研究将表征一种新的多功能TCR近端蛋白。
英文摘要
We recently isolated a novel protein, SLAT, member of a novel subfamily of Rac-specific activators.
SLAT is upregulated in Th2 cells and antigen stimulation induces its immune synapse localization and ZAP-
70 association, leading to reduced TCR recruitment and activation of ZAP-70. Our two, non-exclusive.
working hypotheses are:1) SLAT, via its association ZAP-70, inhibits the kinase's TCR recruitment and/or
activation, thereby modulating the quality of TCR signaling in a manner that promotes Th2 differentiation,
expansion and/or activation; and 2) SLAT and/or its alternative product, SLAT2, functions in Th2 cells as a
Cdc42/Rac-specific GEF; this activity plays a non-redundant and unique role in determining the distinct
quality of the IS and lipid raft clustering and, consequently, downstream signals, in Th2 cells. We will address
these hypotheses and analyze other aspects of the expression, function and regulation of SLAT by exploring
four aims: 1) Using primary mouse T cells, imaging and biochemical techniques, different stimuli, and
receptor-blocking antibodies, we will analyze the expression of SLAT/SLAT2 mRNA or protein, study their
intracellular localization, map residues essential for the membrane/IS localization, and assess the
significance of this localization. 2) We will conduct a detailed analysis of SLAT1" mice, including Th1/Th2
differentiation, proximal and downstream signaling events, antibody and T cell responses, and susceptibility
to experimental diseases that are associated with predominance of the Th1 or Th2 phenotype. 3) We will
explore the biological relevance of the association between SLAT and ZAP-70 (or Syk) by mapping the
interaction sites, and assessing the effects of interaction-deficient SLAT or ZAP-70/Syk mutants, or dominant
negative ZAP-70/Syk, on Th1/Th1 development and activation. 4) We will use biochemical and genetic
approaches, including SLAT1' mice or T cells reconstituted with SLAT mutants, to map the SLAT residues
responsible for GEF activity, study mechanisms that regulate the GEF activity of SLAT, and determine the
significance of this activity for the Th2-skewing effect of SLAT and for distinct organization of the IS in Th2
cells. These studies will characterize a novel, multifunctional TCR-proximal protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of Teff/Treg cells by novel PKC-theta allosteric inhibitory strategies
-
批准号:8771233
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2014
-
负责人:AMNON ALTMAN
-
依托单位:
7th International Leukocyte Signal Transduction Conference
-
批准号:8594061
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2013
-
负责人:AMNON ALTMAN
-
依托单位:
Global protein palmitoylation and DHHC proteins in T cell activation and anergy
-
批准号:8238986
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
The 6th International Leukocyte Signal Transduction Workshop
-
批准号:8205423
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
Global protein palmitoylation and DHHC proteins in T cell activation and anergy
-
批准号:8766542
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
Global protein palmitoylation and DHHC proteins in T cell activation and anergy
-
批准号:8385513
-
项目类别:
-
资助金额:$41.92万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
Global protein palmitoylation and DHHC proteins in T cell activation and anergy
-
批准号:8590200
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
Regulation of T cell anergy by palmitoyl acyl transferases
-
批准号:7753678
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2009
-
负责人:AMNON ALTMAN
-
依托单位:
The 5th International Leukocyte Signal Transduction Workshop
-
批准号:7688398
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2009
-
负责人:AMNON ALTMAN
-
依托单位:
Regulation of T cell anergy by palmitoyl acyl transferases
-
批准号:7571748
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2009
-
负责人:AMNON ALTMAN
-
依托单位:
The Fourth International Leukocyte Signal Transduction Workshop: Clinical Implica
-
批准号:7278001
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:AMNON ALTMAN
-
依托单位:
Immune regulation by SLAT, a Novel Th2-Expressed Protein
-
批准号:7771711
-
项目类别:
-
资助金额:$44.75万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
SLAT: A novel GEF coordinating actin remodeling and Ca2+ signaling in T cells
-
批准号:8041138
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
SLAT: A novel GEF coordinating actin remodeling and Ca2+ signaling in T cells
-
批准号:8432835
-
项目类别:
-
资助金额:$42.72万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
Immune regulation by SLAT, a Novel Th2-Expressed Protein
-
批准号:7570019
-
项目类别:
-
资助金额:$45.2万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
SLAT: A novel GEF coordinating actin remodeling and Ca2+ signaling in T cells
-
批准号:8619577
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
Immune regulation by SLAT, a Novel Th2-Expressed Protein
-
批准号:7049873
-
项目类别:
-
资助金额:$47.45万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
Immune regulation by SLAT, a Novel Th2-Expressed Protein
-
批准号:7187391
-
项目类别:
-
资助金额:$46.07万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
SLAT: A novel GEF coordinating actin remodeling and Ca2+ signaling in T cells
-
批准号:8206605
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
PKC Theta--A Novel Drug Target in T Cell Leukemias
-
批准号:6466120
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2002
-
负责人:AMNON ALTMAN
-
依托单位:
海外基金